Explore the Potential with AI-Driven Innovation
This comprehensive focused library is produced on demand with state-of-the-art virtual screening and parameter assessment technology driven by Receptor.AI drug discovery platform. This approach outperforms traditional methods and provides higher-quality compounds with superior activity, selectivity and safety.
The compounds are cherry-picked from the vast virtual chemical space of over 60B molecules. The synthesis and delivery of compounds is facilitated by our partner Reaxense.
Contained in the library are leading modulators, each labelled with 38 ADME-Tox and 32 physicochemical and drug-likeness qualities. In addition, each compound is illustrated with its optimal docking poses, affinity scores, and activity scores, giving a complete picture.
Our high-tech, dedicated method is applied to construct targeted libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
It includes comprehensive molecular simulations of the catalytic and allosteric binding pockets and the ensemble virtual screening accounting for their conformational mobility. In the case of designing modulators, the structural changes induced by reaction intermediates are taken into account to leverage activity and selectivity.
Our library stands out due to several important features:
partner
Reaxense
upacc
O95376
UPID:
ARI2_HUMAN
Alternative names:
RING-type E3 ubiquitin transferase ARIH2; Triad1 protein
Alternative UPACC:
O95376; Q9HBZ6; Q9UEM9
Background:
E3 ubiquitin-protein ligase ARIH2, also known as RING-type E3 ubiquitin transferase ARIH2 or Triad1 protein, plays a pivotal role in ubiquitination processes. It catalyzes the ubiquitination of target proteins in collaboration with ubiquitin-conjugating enzyme E2 UBE2L3. ARIH2 functions uniquely by associating with the cullin-5-RING ubiquitin ligase complex (ECS complex or CRL5 complex), initiating the addition of the first ubiquitin on ECS targets. This activity is crucial for the regulation of 'Lys-6', 'Lys-48'-, and 'Lys-63'-linked polyubiquitination, impacting various cellular processes.
Therapeutic significance:
Understanding the role of E3 ubiquitin-protein ligase ARIH2 could open doors to potential therapeutic strategies.